Specialties

Rheumatology

Conferences Earn CME/CE

More Conferences

Featured CME/CE Activities

More CME Activities

Click for Credit Free CME/CE

NSAIDs a significant mediator of cardiovascular risk in osteoarthritis

NSAID use could be responsible for a significant proportion of the increased risk of cardiovascular disease associated with osteoarthritis.

First adult APS recommendations released by European society

MADRID ­– The EULAR recommendations also cover secondary prevention and management of recurrent episodes and catastrophic APS, for which new recommendations have been separately developed.

Repeated ANA testing after negative result of little diagnostic value

MADRID ­– In a retrospective analysis, 79% of repeated antinuclear antibody tests for ANA-associated rheumatologic conditions remained the same.

Cardiovascular events in U.S. RA patients fall to non-RA level

MADRID – U.S. rheumatoid arthritis patients had excess cardiovascular disease events for decades, but that changed during 2000-2009.

More Click for Credit

Conference News & Video

Ixekizumab psoriasis outcomes, sliced and diced

WAIKOLOA, HAWAII – The jaw-dropping NNT to achieve complete skin clearance: 2.6 patients.

What’s new with adalimumab? Plenty

WAIKOLOA, HAWAII – New information includes reassuring new long-term, real-world safety data, plus a simple early predictor of PASI 75 response.

Guselkumab tops secukinumab over 48 weeks for plaque psoriasis

CAYMAN ISLANDS – In both groups, the PASI 90 increased similarly in the first month, but was consistently higher in the guselkumab group at week 12 and after.

More Conference News & Video

Scientific Abstracts

There are no results under this Specialty.

More Scientific Abstracts